We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $73.4B Turnover 30.34%
1-Year Est. Return 32.8%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+9.73%
1 Year Est. Return
+32.8%
3 Year Est. Return
+177.41%
5 Year Est. Return
+184.82%
10 Year Est. Return
+833.33%
AUM
$80.4B
AUM Growth
-$11.7B
Cap. Flow
-$16B
Cap. Flow %
-19.95%
Top 10 Hldgs %
10.17%
Holding
3,937
New
591
Increased
1,067
Reduced
1,579
Closed
676
Avg Time Held
2.7 years
Top 10 Avg Time Held
0.9 years
Top 20 Avg Time Held
1.5 years

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$427M
2
ROKU icon
Roku
ROKU
+$393M
3
PARA icon
Paramount Global Class B
PARA
+$345M
4
T icon
AT&T
T
+$317M
5
QCOM icon
Qualcomm
QCOM
+$293M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$1.41B
2
PDD icon
Pinduoduo
PDD
+$755M
3
BMY icon
Bristol-Myers Squibb
BMY
+$716M
4
ABBV icon
AbbVie
ABBV
+$558M
5
CMG icon
Chipotle Mexican Grill
CMG
+$491M

Sector Composition

Rank Sector Weight
1 Healthcare 19.86%
2 Technology 17.77%
3 Communication Services 11.51%
4 Consumer Discretionary 10.66%
5 Consumer Staples 10.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NVO icon
1
Novo Nordisk
NVO
$167B
$1.68B 2.08%
49,693,342
-3,989,000
-7% -$142M
2013 Q2
31 quarters
VRSN icon
2
VeriSign
VRSN
$27.5B
$968M 1.2%
4,868,314
-853,220
-15% -$168M
2013 Q2
31 quarters
ZM icon
3
Zoom
ZM
$23.7B
$810M 1.01%
2,520,863
+132,329
+6% +$48.7M
2020 Q1
4 quarters
MNST icon
4
Monster Beverage
MNST
$85.5B
$725M 0.9%
31,827,040
-9,091,600
-22% -$204M
2014 Q1
28 quarters
TGT icon
5
Target
TGT
$75.1B
$710M 0.88%
3,586,059
-1,759,606
-33% -$329M
2019 Q1
8 quarters
TEAM icon
6
Atlassian
TEAM
$33.9B
$704M 0.88%
3,341,420
-1,003,600
-23% -$234M
2016 Q2
19 quarters
BIDU icon
7
Baidu
BIDU
$21.1B
$697M 0.87%
3,204,791
-5,385,073
-63% -$1.41B
2019 Q3
6 quarters
PANW icon
8
Palo Alto Networks
PANW
$282B
$664M 0.83%
12,378,780
-5,937,594
-32% -$353M
2015 Q2
23 quarters
KR icon
9
Kroger
KR
$40.4B
$618M 0.77%
17,174,071
-7,473,144
-30% -$255M
2019 Q2
7 quarters
FNV icon
10
Franco-Nevada
FNV
$43.1B
$606M 0.75%
4,837,390
-705,200
-13% -$84.9M
2014 Q1
28 quarters
VOD icon
11
Vodafone
VOD
$32.5B
$595M 0.74%
32,310,076
-4,672,900
-13% -$84.5M
2015 Q3
22 quarters
MOH icon
12
Molina Healthcare
MOH
$10.4B
$577M 0.72%
2,466,415
-633,950
-20% -$141M
2013 Q2
31 quarters
ABMD
13
DELISTED
Abiomed Inc
ABMD
$567M 0.71%
1,780,123
-213,677
-11% -$68.4M
2015 Q1
24 quarters
TSLA icon
14
Tesla
TSLA
$1.37T
$553M 0.69%
2,482,143
+1,699,518
+217% +$427M
2018 Q4
9 quarters
BIIB icon
15
Biogen
BIIB
$36.9B
$542M 0.67%
1,938,162
-1,099,600
-36% -$297M
2018 Q1
12 quarters
UTHR icon
16
United Therapeutics
UTHR
$23.6B
$537M 0.67%
3,207,591
-399,700
-11% -$66.6M
2013 Q2
31 quarters
HSY icon
17
Hershey
HSY
$35.3B
$532M 0.66%
3,361,261
-20,005
-0.6% -$3.01M
2013 Q2
31 quarters
VRTX icon
18
Vertex Pharmaceuticals
VRTX
$131B
$516M 0.64%
2,400,284
-1,175,646
-33% -$258M
2017 Q1
16 quarters
ALXN
19
DELISTED
Alexion Pharmaceuticals
ALXN
$509M 0.63%
3,328,121
-785,583
-19% -$122M
2018 Q3
10 quarters
FFIV icon
20
F5
FFIV
$17.3B
$500M 0.62%
2,397,136
-621,700
-21% -$122M
2014 Q3
26 quarters
HZNP
21
DELISTED
Horizon Therapeutics
HZNP
$480M 0.6%
5,209,963
-1,589,000
-23% -$134M
2017 Q2
15 quarters
ROKU icon
22
DELISTED
Roku
ROKU
$474M 0.59%
1,455,700
+1,001,745
+221% +$393M
2020 Q3
2 quarters
ETSY icon
23
Etsy
ETSY
$6.6B
$465M 0.58%
2,308,208
-1,521,900
-40% -$319M
2015 Q4
21 quarters
FTNT icon
24
Fortinet
FTNT
$91.5B
$447M 0.56%
12,123,420
-5,579,000
-32% -$183M
2015 Q3
22 quarters
GOOGL icon
25
Alphabet (Google) Class A
GOOGL
$3.26T
$442M 0.55%
4,286,960
+448,000
+12% +$44.2M
2018 Q3
10 quarters

Similar funds

Jim Simons's Q1 2021 Portfolio in Review

As of Q1 2021, Jim Simons held 3,937 positions worth $80.4B, down 13% from $92.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Jim Simons withdrew a net $16B in Q1 2021, closing 676 positions and reducing 1,579 holdings. Its most notable exit was Micron Technology, an estimated $252M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Jim Simons opened a new position in Paramount Global Class B worth $255M.

  • Jim Simons's largest Q1 2021 buy was Paramount Global Class B: 5,644,997 shares worth $255M.
  • Jim Simons added most to Tesla in Q1 2021, an estimated $427M increase.
  • Jim Simons's biggest Q1 2021 reduction was Baidu, cutting an estimated $1.41B.
  • Jim Simons fully exited Micron Technology in Q1 2021, selling an estimated $252M.
  • Jim Simons's ten largest holdings make up 10% of its $80.4B portfolio in Q1 2021.
  • Jim Simons opened 591 new positions and closed 676 in Q1 2021.
  • Jim Simons's portfolio value fell 13% quarter-over-quarter to $80.4B.

Based on Renaissance Technologies's 13F filing for Q1 2021, filed 13 May 2021.